SEC Filing Summary: RYVYL Inc. (RVYL)
Business Context and Reporting Period
This Form 8-K was filed by RYVYL Inc. (not RTB Digital, Inc.) on April 11, 2025, reporting an event dated April 8, 2025. The Company is a Nevada corporation listed on the Nasdaq Capital Market under the symbol "RVYL."
Key Financial Metrics
The filing discloses specific equity data but does not provide revenue, profit, cash flow, or debt figures.
- Stockholders' Equity: ($1,492,000) as of December 31, 2024.
- Listing Requirement: Minimum stockholders' equity of $2.5 million under Nasdaq Listing Rule 5550(b)(1).
Material Changes
The Company received written notice from Nasdaq on April 8, 2025, stating it is no longer in compliance with the minimum stockholders' equity requirement due to negative equity of $1.492 million. This represents a material deviation from the $2.5 million threshold required for continued listing.
Outlook, Risks, and Management Commentary
Compliance Plan: The Company has until May 23, 2025, to submit a plan to regain compliance. If accepted, Nasdaq may grant an extension of up to 180 calendar days from April 8, 2025, to evidence compliance.
Trading Status: The notice has no immediate effect on the listing or trading of the Company's common stock; trading will continue on the Nasdaq Capital Market.
Risks and Contingencies:
- Failure to meet the minimum stockholders' equity requirement within the required timeframe.
- Potential rejection of the compliance plan by Nasdaq.
- Uncertainties regarding the termination of the sale of Ryvyl EU and the ability to raise capital.
- Regulatory environment changes, technology shifts, and banking sector turmoil.
- Potential damages from previously announced litigation or governmental actions.
Investor Verification Checklist
- Verify the Company's plan to regain compliance submitted by May 23, 2025.
- Monitor Nasdaq's decision on the acceptance of the compliance plan and any granted extensions.
- Review the Company's ability to raise capital to address the negative equity position.
- Check for updates on the termination of the Ryvyl EU sale and related litigation risks.